This hub covers epilepsy devices and neuromodulation like VNS, RNS, and DBS, which are treatments that can reduce seizures when meds aren’t enough. Plain-language research summaries plus real-life pros/cons.
Some are used more often in adults, but pediatric use depends on the device, the case, and specialist guidance.
Often gradually. Improvement can build over months as settings are optimized.
Sometimes medication can be reduced, but many people still use meds alongside a device.
Sometimes yes, with device-specific rules. Always check the exact device guidelines first.
Researchers studied the outcomes of pediatric epilepsy surgery by examining data from 100 procedures performed on 62 children and young adults.
This study looked at the effects of deep brain stimulation (DBS) on adults with drug-resistant epilepsy (DRE) who had not found relief from other treatments, including vagus nerve stimulation (VNS).
This study looked at two different forms of cannabidiol (CBD) to see how they are absorbed and how safe they are.
This study looked at childhood absence epilepsy (CAE), a common type of epilepsy that affects children, particularly those in school.
This study focuses on understanding how certain brain activity patterns, seen in electroencephalograms (EEGs), can help predict the recovery of people who survive cardiac arrest.
Researchers studied the unique challenges faced by women with epilepsy (WWE) throughout different stages of their lives.
Researchers studied how brain networks are affected in people with nonlesional focal epilepsy, which is a type of epilepsy that doesn’t show visible brain damage on scans.
This study looked at adults who experienced a first episode of status epilepticus (SE), a serious condition where seizures last too long or happen back-to-back.
Researchers studied how deep learning (DL) techniques can help locate the epileptogenic zone (EZ), which is the area in the brain that causes seizures, in people with drug-resistant epilepsy.